PROQR THERAPEUTICS (Germany) Price Prediction

0PQ Stock  EUR 2.15  0.03  1.38%   
The value of RSI of PROQR THERAPEUTICS's the stock price is roughly 63. This suggests that the stock is rather overbought by investors as of 29th of March 2024. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling PROQR, making its price go up or down.

Oversold Vs Overbought

63

 
Oversold
 
Overbought
PROQR THERAPEUTICS EO-04 stock price prediction is an act of determining the future value of PROQR THERAPEUTICS shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of PROQR THERAPEUTICS's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of PROQR THERAPEUTICS and does not consider all of the tangible or intangible factors available from PROQR THERAPEUTICS's fundamental data. We analyze noise-free headlines and recent hype associated with PROQR THERAPEUTICS EO 04, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of PROQR THERAPEUTICS based on different types of headlines from major news networks to social media. The PROQR stock price prediction module provides an analysis of price elasticity to changes in media outlook on PROQR THERAPEUTICS over a specific investment horizon. Using PROQR THERAPEUTICS hype-based prediction, you can estimate the value of PROQR THERAPEUTICS EO 04 from the perspective of PROQR THERAPEUTICS response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in PROQR THERAPEUTICS. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in PROQR THERAPEUTICS to buy its stock at a price that has no basis in reality. In that case, they are not buying PROQR because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

PROQR THERAPEUTICS after-hype prediction price

    
  EUR 2.15  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out PROQR THERAPEUTICS Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PROQR THERAPEUTICS's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.091.807.18
Details
Naive
Forecast
LowNextHigh
0.042.137.51
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.142.162.19
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as PROQR THERAPEUTICS. Your research has to be compared to or analyzed against PROQR THERAPEUTICS's peers to derive any actionable benefits. When done correctly, PROQR THERAPEUTICS's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in PROQR THERAPEUTICS EO-04.

PROQR THERAPEUTICS After-Hype Price Prediction Density Analysis

As far as predicting the price of PROQR THERAPEUTICS at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in PROQR THERAPEUTICS or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of PROQR THERAPEUTICS, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

PROQR THERAPEUTICS Estimiated After-Hype Price Volatility

In the context of predicting PROQR THERAPEUTICS's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on PROQR THERAPEUTICS's historical news coverage. PROQR THERAPEUTICS's after-hype downside and upside margins for the prediction period are 0.11 and 7.53, respectively. We have considered PROQR THERAPEUTICS's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.15
2.15
After-hype Price
7.53
Upside
PROQR THERAPEUTICS is dangerous at this time. Analysis and calculation of next after-hype price of PROQR THERAPEUTICS EO-04 is based on 3 months time horizon.

PROQR THERAPEUTICS Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as PROQR THERAPEUTICS is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PROQR THERAPEUTICS backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PROQR THERAPEUTICS, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.47 
5.38
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.15
2.15
0.00 
0.00  
Notes

PROQR THERAPEUTICS Hype Timeline

PROQR THERAPEUTICS EO-04 is presently traded for 2.15on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. PROQR is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is presently at 0.47%. %. The volatility of related hype on PROQR THERAPEUTICS is about 0.0%, with the expected price after the next announcement by competition of 2.15. About 21.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 0.92. PROQR THERAPEUTICS EO-04 had not issued any dividends in recent years. Assuming the 90 days horizon the next estimated press release will be in 5 to 10 days.
Check out PROQR THERAPEUTICS Basic Forecasting Models to cross-verify your projections.

PROQR THERAPEUTICS Related Hype Analysis

Having access to credible news sources related to PROQR THERAPEUTICS's direct competition is more important than ever and may enhance your ability to predict PROQR THERAPEUTICS's future price movements. Getting to know how PROQR THERAPEUTICS rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how PROQR THERAPEUTICS may potentially react to the hype associated with one of its peers.

PROQR THERAPEUTICS Additional Predictive Modules

Most predictive techniques to examine PROQR price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PROQR using various technical indicators. When you analyze PROQR charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About PROQR THERAPEUTICS Predictive Indicators

The successful prediction of PROQR THERAPEUTICS stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as PROQR THERAPEUTICS EO 04, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of PROQR THERAPEUTICS based on analysis of PROQR THERAPEUTICS hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to PROQR THERAPEUTICS's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PROQR THERAPEUTICS's related companies.

Story Coverage note for PROQR THERAPEUTICS

The number of cover stories for PROQR THERAPEUTICS depends on current market conditions and PROQR THERAPEUTICS's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that PROQR THERAPEUTICS is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about PROQR THERAPEUTICS's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Check out PROQR THERAPEUTICS Basic Forecasting Models to cross-verify your projections.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for PROQR Stock analysis

When running PROQR THERAPEUTICS's price analysis, check to measure PROQR THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PROQR THERAPEUTICS is operating at the current time. Most of PROQR THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of PROQR THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PROQR THERAPEUTICS's price. Additionally, you may evaluate how the addition of PROQR THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Please note, there is a significant difference between PROQR THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if PROQR THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PROQR THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.